Markets:

Overview

News

Currencies

International

Treasuries

Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

1.810 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Inovio Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Why Are Inovio Shares Plummeting Today ↗

May 11, 2022

Via Benzinga

The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine ↗

May 11, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 11, 2022

Via Benzinga

34 Stocks Moving in Wednesday's Pre-Market Session ↗

May 11, 2022

Gainers Embark Technology, Inc. (NASDAQ: EMBK) rose 36.4% to $1.95 in pre-market trading. Embark Technology posted a Q1 loss of $0.04 per share.

Via Benzinga

Earnings Scheduled For March 1, 2022 ↗

March 01, 2022

Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated...

Via Benzinga

Inovio Pharmaceuticals: Q1 Earnings Insights ↗

May 10, 2022

Inovio Pharmaceuticals (NASDAQ:INO) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 10, 2022

Gainers Avalon Globocare (NASDAQ:AVCO) stock rose 14.8% to $0.54 during Tuesday's after-market session. The market value of their outstanding shares is at $47.8 million.

Via Benzinga

The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More ↗

May 09, 2022

Biotech stocks declined yet again in the week ending May 6, dragged lower by macroeconomic concerns following the Federal Reserve's 50-basis-point rate hike. The iShares Biotechnology ETF (NASDAQ:...

Via Benzinga

7 F-Rated Penny Stocks Not Worth the Gamble ↗

April 26, 2022

In a market with this kind of downside bias there are plenty of stocks that are on sale, so make sure to avoid bad penny stocks when buying.

Via InvestorPlace

68 Biggest Movers From Yesterday ↗

March 03, 2022

Gainers ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday. Imperial Petroleum Inc. (NASDAQ: IMPP) shares jumped 39.2% to...

Via Benzinga

41 Stocks Moving In Wednesday's Mid-Day Session ↗

March 02, 2022

Gainers ECMOHO Limited (NASDAQ: MOHO) jumped 67% to $0.3890 after jumping 10% on Tuesday. Nordstrom, Inc. (NYSE: JWN) shares jumped 38.7% to $27.11 after the company reported...

Via Benzinga

Lab Study Shows Inovio's COVID-19 Vaccine Candidate Weaker Against Omicron Variant ↗

March 02, 2022

Tucked in the Q4 earnings release, Inovio Pharmaceuticals Inc (NASDAQ: INO) has paused enrollment for an ongoing INNOVATE Phase 3 trial of its lead COVID-19 vaccine...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 02, 2022

Gainers IsoPlexis (NASDAQ:ISO) shares moved upwards by 22.8% to $5.5 during Wednesday's pre-market session. The company's market cap stands at $214.2 million. The...

Via Benzinga

The Daily Biotech Pulse: Karyopharm Flags Delay In Selinexor Label Expansion, Finch, Celyad Hit With Clinical Holds, Adagene Strikes R&D Collaboration With Sanofi ↗

March 02, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Karyopharm Says FDA Mandates Additional Study For Expanding Selinexor Label...

Via Benzinga

28 Stocks Moving in Wednesday's Pre-Market Session ↗

March 02, 2022

Gainers Guardion Health Sciences, Inc. (NASDAQ: GHSI) rose 46.4% to $0.4098 in pre-market trading after jumping around 48% on Tuesday. Guardion Health Sciences recently reported...

Via Benzinga

Inovio Pharmaceuticals: Q4 Earnings Insights ↗

March 01, 2022

Inovio Pharmaceuticals (NASDAQ:INO) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 01, 2022

Gainers Organogenesis Holdings (NASDAQ:ORGO

Via Benzinga

The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution ↗

March 01, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Editas Gains On Resolution Of CRISPR Gene Editing Patent Case Editas Medicine...

Via Benzinga

The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight ↗

February 27, 2022

Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first...

Via Benzinga

Thinking About Buying Stock In AMC Entertainment, Romeo Power Or Inovio Pharmaceuticals? ↗

February 24, 2022

Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings b...

Via Benzinga

Why This Analyst Has Increased Confidence In Inovio Pharmaceuticals ↗

January 21, 2022

Following the recent pullback in Inovio Pharmaceuticals Inc.’s (NASDAQ:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 21, 2022 ↗

January 21, 2022

Upgrades According to Seaport Global, the prior rating for KB Home (NYSE:

Via Benzinga

10 Biggest Price Target Changes For Friday ↗

January 21, 2022

Barclays cut Netflix, Inc. (NASDAQ: NFLX) price target from $675 to $425. Netflix shares fell 19.6% to $408.58 in pre-market trading. Keybanc cut Chipotle Mexican Grill, Inc...

Via Benzinga

Growing Acceptance Of Digital Health Services is a Huge Boon for Healthcare Cloud Computing Market

January 20, 2022

Palm Beach, FL – January 20, 2022 – FinancialNewsMedia.com News Commentary – Cloud computing increases real-time data collection and improves accessibility to the data. It has outpaced the conventional...

Via FinancialNewsMedia

Bill Gates Says Misinformation Related To Fauci, Himself Doesn't 'Make Sense,' Talks COVID-19 After Omicron ↗

January 11, 2022

Microsoft Corporation (NASDAQ: MSFT) co-founder Bill Gates answered questions related to COVID-19 on Twitter Tuesday. What Happened: The questions to Gates were routed through...

Via Benzinga

Stocks Hitting New 52-Week Lows Today ↗

January 03, 2022

On Monday morning, 60 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows And Highs: Ginkgo Bioworks Holdings (NYSE:DNA) was...

Via Benzinga

Wingstop, Akamai Initiations Among Today's Top Calls On Wall Street ↗

December 29, 2021

Benchmark analyst Todd Brooks initiated coverage of Wingstop (WING) with a Hold rating and no price target. The analyst believes the stock's risk/reward is balanced at these levels given the current

Via Talk Markets

If You Invested $1,000 In Inovio Stock One Year Ago, Here's How Much You'd Have Now ↗

December 27, 2021

Investors who have owned stocks in the last year have generally experienced some big gains. In fact, the SPDR S&P 500 (NYSE: SPY) total return over the last 12 months is 29.2...

Via Benzinga

Market Briefing For Thursday, Dec. 23 ↗

December 23, 2021

'Fortune favors the brave' it is said; it's partially so in this market, where we certainly got the ignition Tuesday of the seasonal rebound we looked for and more on Wednesday.

Via Talk Markets

Why Jim Cramer Likes MGM Growth Properties ↗

December 21, 2021

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Enterprise Products Partners L.P. (NYSE:

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

All News about Inovio Pharmaceuticals, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today